FI104953B - Menetelmä trombolyyttisen koostumuksen valmistamiseksi - Google Patents

Menetelmä trombolyyttisen koostumuksen valmistamiseksi Download PDF

Info

Publication number
FI104953B
FI104953B FI904617A FI904617A FI104953B FI 104953 B FI104953 B FI 104953B FI 904617 A FI904617 A FI 904617A FI 904617 A FI904617 A FI 904617A FI 104953 B FI104953 B FI 104953B
Authority
FI
Finland
Prior art keywords
salt
acid
solution
process according
concentration
Prior art date
Application number
FI904617A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI904617A0 (fi
Inventor
Masahiko Ishibashi
Yukio Shimazaki
Miyuki Kawashima
Ryo Tanaka
Kiyoshi Sakai
Hisahiro Ishiwari
Original Assignee
Mitsui Chemicals Inc
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Chemicals Inc, Mochida Pharm Co Ltd filed Critical Mitsui Chemicals Inc
Publication of FI904617A0 publication Critical patent/FI904617A0/fi
Application granted granted Critical
Publication of FI104953B publication Critical patent/FI104953B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Preliminary Treatment Of Fibers (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI904617A 1989-09-21 1990-09-19 Menetelmä trombolyyttisen koostumuksen valmistamiseksi FI104953B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24331089 1989-09-21
JP24331089 1989-09-21

Publications (2)

Publication Number Publication Date
FI904617A0 FI904617A0 (fi) 1990-09-19
FI104953B true FI104953B (fi) 2000-05-15

Family

ID=17101932

Family Applications (1)

Application Number Title Priority Date Filing Date
FI904617A FI104953B (fi) 1989-09-21 1990-09-19 Menetelmä trombolyyttisen koostumuksen valmistamiseksi

Country Status (15)

Country Link
US (1) US6051223A (de)
EP (1) EP0419252B1 (de)
JP (1) JP2520975B2 (de)
KR (1) KR930008908B1 (de)
CN (1) CN1041799C (de)
AT (1) ATE86867T1 (de)
BR (1) BR9004692A (de)
CA (1) CA2025317C (de)
DE (1) DE69001110T2 (de)
DK (1) DK0419252T3 (de)
ES (1) ES2054263T3 (de)
FI (1) FI104953B (de)
GR (1) GR3007396T3 (de)
NO (1) NO904119L (de)
NZ (1) NZ235298A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207151B1 (en) * 1989-09-21 2001-03-27 Mitsui Chemicals Inc. Aqueous solution of t-PA
US5272076A (en) * 1991-06-13 1993-12-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders using an adduct of t-PA
US6527979B2 (en) * 1999-08-27 2003-03-04 Corazon Technologies, Inc. Catheter systems and methods for their use in the treatment of calcified vascular occlusions
EP2604697B1 (de) * 2006-03-27 2015-07-01 Tokyo University of Agriculture and Technology TLO Triprenylphenolverbindungen, Verfahren zur ihrer Herstellung und Anwendung als Thrombolyseverstärker
EP3524235A1 (de) * 2012-06-11 2019-08-14 The Cleveland Clinic Foundation Behandlung und prävention von herz-kreislauf-erkrankungen und thrombose
CN103191054B (zh) * 2013-04-19 2015-05-27 范克 一种肝素钠封管注射液及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2310133A2 (fr) * 1975-05-05 1976-12-03 Fabre Sa Pierre Nouveau medicament comportant un activateur du plasminogene perfectionne
JPS52145591A (en) * 1976-05-28 1977-12-03 Kanebo Ltd Stabilization of urokinase
JPS5467089A (en) * 1977-11-07 1979-05-30 Dainippon Pharmaceut Co Ltd Urokinase composition
JPS5568290A (en) * 1978-11-16 1980-05-22 Kanebo Ltd Stabilization of urokinase
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
JPS60158116A (ja) * 1984-01-30 1985-08-19 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
JPS60158117A (ja) * 1984-01-30 1985-08-19 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
JPS60181028A (ja) * 1984-02-29 1985-09-14 Asahi Chem Ind Co Ltd 組織プラスミノ−ゲン・アクチベ−タ−の溶解補助法
JPS60184026A (ja) * 1984-03-01 1985-09-19 Asahi Chem Ind Co Ltd 組織プラスミノ−ゲン・アクチベ−タ−の溶解補助方法
GR860624B (en) * 1985-03-06 1986-07-08 Survival Technology T-pa composition and method of getting into blood steam
DE3512908A1 (de) * 1985-04-11 1986-10-23 Behringwerke Ag, 3550 Marburg Gewebe-plasminogenaktivator (t-pa) enthaltendes mittel
DE3512910A1 (de) * 1985-04-11 1986-10-16 Behringwerke Ag, 3550 Marburg Verfahren zur reinigung von plasminogenaktivatoren
DE3512909A1 (de) * 1985-04-11 1986-10-23 Behringwerke Ag, 3550 Marburg Verfahren zur bestimmung von plasminogenaktivatoren (pa)
JPH0669960B2 (ja) * 1985-11-22 1994-09-07 エーザイ株式会社 水溶性を増加したｔＰＡ含有医薬組成物
DE3687255T2 (de) * 1985-09-10 1993-05-06 Eisai Co Ltd Einen gewebe-plasminogen-aktivator enthaltende zusammensetzung.
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
JPS62120321A (ja) * 1985-11-20 1987-06-01 Eisai Co Ltd ｔＰＡ含有医薬組成物
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
JPH0678241B2 (ja) * 1986-04-02 1994-10-05 エーザイ株式会社 ｔＰＡ医薬組成物
JPS62292729A (ja) * 1986-06-12 1987-12-19 Toyobo Co Ltd ヒト子宮組織由来プラスミノ−ゲン活性化因子製剤
US4857320A (en) * 1987-02-19 1989-08-15 Monsanto Company Method of enhancing the solubility of tissue plasminogen activator
DE3718889A1 (de) * 1987-06-05 1988-12-22 Behringwerke Ag Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin
JP2708749B2 (ja) * 1987-08-10 1998-02-04 エーザイ株式会社 修飾型ｔＰＡ含有注射用組成物
US4898826A (en) * 1987-12-10 1990-02-06 Invitron Corporation Method to solubilize tissue plasminogen activator
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
JPH06226234A (ja) * 1993-02-01 1994-08-16 Shojiro Takeuchi 産業廃棄物の炭化処理方法
JPH06236332A (ja) * 1993-02-09 1994-08-23 Oki Electric Ind Co Ltd プログラムローディング装置
JPH06259221A (ja) * 1993-03-05 1994-09-16 Tokyo Electric Co Ltd 画面表示器を備えた情報処理装置
JPH06281326A (ja) * 1993-03-30 1994-10-07 Shibaura Eng Works Co Ltd 洗浄物の乾燥方法

Also Published As

Publication number Publication date
NZ235298A (en) 1992-12-23
JP2520975B2 (ja) 1996-07-31
GR3007396T3 (de) 1993-07-30
US6051223A (en) 2000-04-18
DK0419252T3 (da) 1993-04-19
CN1050321A (zh) 1991-04-03
NO904119L (no) 1991-03-22
CA2025317A1 (en) 1991-03-22
CN1041799C (zh) 1999-01-27
NO904119D0 (no) 1990-09-20
AU619697B2 (en) 1992-01-30
DE69001110T2 (de) 1993-06-24
AU6246790A (en) 1991-03-28
EP0419252B1 (de) 1993-03-17
ES2054263T3 (es) 1994-08-01
JPH0418032A (ja) 1992-01-22
FI904617A0 (fi) 1990-09-19
KR930008908B1 (ko) 1993-09-17
EP0419252A1 (de) 1991-03-27
DE69001110D1 (de) 1993-04-22
BR9004692A (pt) 1991-09-10
KR910005883A (ko) 1991-04-27
ATE86867T1 (de) 1993-04-15
CA2025317C (en) 1996-05-07

Similar Documents

Publication Publication Date Title
EP0876155B1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
US7311908B2 (en) Pharmaceutical compositions of fibrinolytic agent
KR0127754B1 (ko) 항응고제
JPH0672105B2 (ja) 血栓溶解剤及びその製法
JPS6236332A (ja) 医薬投与単位
FI104953B (fi) Menetelmä trombolyyttisen koostumuksen valmistamiseksi
CN104414977A (zh) 一种注射用青蒿琥酯和l-精氨酸组合物及其制备方法
JPH0222233A (ja) スーパーオキシドディスムターゼ組成物
EP0419251B1 (de) Protein enthaltende wässerige Lösungen
US5366730A (en) Stabilized compositions having human tissue type plasminogen activator enzymatic activity
CN105412942A (zh) 聚乙二醇化的重组产朊假丝酵母尿酸氧化酶冻干注射剂
JP6375112B2 (ja) テネクテプラーゼの医薬組成物
US6207151B1 (en) Aqueous solution of t-PA
CA2046598C (en) T-pa solubilisation
FI98601C (fi) Menetelmä glykosyloimattoman t-PA-johdannaisen K1K2P farmaseuttisen valmisteen valmistamiseksi
JPH1112194A (ja) 組織プラスミノーゲン活性化因子医薬組成物
CN117858696A (zh) 一种能皮下给药的抗生素药物组合物
JPH07278015A (ja) ヒト尿性トリプシンインヒビター含有液状製剤
JP2001081040A (ja) 組織プラスミノーゲンアクティベーター含有組成物
JP2005035921A (ja) 組織プラスミノーゲン活性化因子含有製剤
AU2006200638A1 (en) Pharmaceutical compositions of fibrinolytic agent

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: MITSUI CHEMICALS, INC.

MM Patent lapsed

Owner name: SCHERING AKTIENGESELLSCHAFT